<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <article-meta>
      <title-group>
        <article-title>Study on impact of patient related variables on CD4 count and opportunistic infections in HIV seropositives</article-title>
      </title-group>
      <contrib-group content-type="author">
        <contrib contrib-type="person">
          <name>
            <given-names>Divya Yedluri</given-names>
          </name>
          <email>divyayedluri9@gmail.com</email>
          <xref ref-type="aff" rid="aff-1"/>
        </contrib>
      </contrib-group>
      <aff id="aff-1">
        <institution>Department of Pharmacy Practice, Chalapathi Institute of Pharmaceutical Sciences, Guntur</institution>
        <country>India</country>
      </aff>
      <history>
        <date date-type="received" iso-8601-date="2020-08-10">
          <day>10</day>
          <month>08</month>
          <year>2020</year>
        </date>
        <date data-type="published" iso-8601-date="2020-08-10">
          <day>10</day>
          <month>08</month>
          <year>2020</year>
        </date>
      </history>
    </article-meta>
  </front>
  <body>
    <fig>
      <graphic mimetype="image" mime-subtype="jpeg" xlink:href="image1.jpeg"/>
    </fig>
    <p>
      <bold>www.ijamscr.com</bold>
    </p>
    <sec id="sec-1">
      <title>Study on impact of patient related variables on CD<sub>4</sub> count and opportunistic infections in HIV seropositives</title>
      <sec id="sec-1_1">
        <title>Divya Yedluri<sup>1</sup>, Varoodha Kanneboina<sup>2</sup>, Jyothsna Medarametla<sup>3</sup>, Prathyusha Suddapalli<sup>4</sup>. </title>
        <p>
          <italic>
            <sup>1</sup>
          </italic>
          <italic>Department of Pharmacy Practice, Chalapathi Institute of Pharmaceutical Sciences, Guntur</italic>
        </p>
        <p>
          <italic>
            <sup>2</sup>
          </italic>
          <italic>Department of Pharmacy Practice, Chalapathi Institute of Pharmaceutical Sciences, Guntur</italic>
        </p>
        <p>
          <italic>
            <sup>3</sup>
          </italic>
          <italic>Department of Pharmacy Practice, Chalapathi Institute of Pharmaceutical Sciences, Guntur</italic>
        </p>
        <p>
          <italic>
            <sup>4</sup>
          </italic>
          <italic>Department of Pharmacy Practice, Chalapathi Institute of Pharmaceutical Sciences, Guntur</italic>
        </p>
        <p><bold>Corresponding Author</bold>: <bold>Divya Yedluri</bold> </p>
        <p><bold>Email id:</bold> <bold>divyayedluri9@gmail.com</bold></p>
        <sec id="sec-1_1_1">
          <title>ABSTRACT</title>
          <p>
            <bold>Background</bold>
          </p>
          <p>Opportunistic infections are the hallmark manifestations of AIDS. To decrease the incidence of OI’s in PLHIV, there is a need to study the impact of all relevant factors which may be a key for the development of OI’s.</p>
          <p>
            <bold>Aim</bold>
          </p>
          <p>To study the impact of patient related variables on CD<sub>4</sub> count and opportunistic infections in people living with HIV.</p>
          <p>
            <bold>Methods and methodology</bold>
          </p>
          <p>A Prospective Observational study was carried out at ART center. HIV patients who met inclusion criteria were informed consented and included in the study and relevant data was collected in a prior designed data collection form.</p>
          <p>
            <bold>Results</bold>
          </p>
          <p>A total of 214 patients having OI’s were included among which 55.1% (n=118) were women and 44.9% (n= 96) were men. Most of the OI’s occurred in the age group of 31- 40 yrs. (n=85; 39.17%) and when CD<sub>4</sub> count was between 100-350 cells/mm3. TB was the most common OI (n=115; 50%) followed by candidiasis (n= 110; 47.8%). When BMI was correlated with CD<sub>4</sub>; it revealed that underweight was predominant (n=62; 79.49%) when CD<sub>4</sub> count was &lt; 350 cells/mm3. Grade II anemia was most common (n=97; 49.24%) and most of the patients with OI’s belong to upper lower class (n=179; 83.64%) according to KSES. Risk grading using JDPV scale reveals 107 (50%) patients fall under high risk category and 64 (29.3%) , 4 (1.87%) are with moderate and high risk respectively.</p>
          <p>
            <bold>Conclusion</bold>
          </p>
          <p>This study reveals that there is a positive relationship between BMI and CD<sub>4</sub> count and it also shows that the incidence of OIs is influenced by multiple factors which should be considered to provide appropriate care to the patient.</p>
        </sec>
        <sec id="sec-1_1_2">
          <title>INTRODUCTION</title>
          <p>Acquired Immunodeficiency Syndrome (AIDS) ranks third place for most of the deaths across the globe and its main manifestations are opportunistic infections. Opportunistic infections occur when person’s immunity is significantly weak and have significant impact on quality of life and grossly effects health of HIV patients. OI’s vary from region to region across the world based on demographics of the nation and epidemics within the community also play a significant role in its incidence and prevalence. Treatment to restrict the progression of disease using antiretroviral drugs of different mechanisms is of no use due to rapid mutations in genomic complex of HIV [1, 3, 5]. Though the prognosis has improved due to HAART in HIV but unfortunately therapeutic challenges still dominate the ART therapy which includes Drug Toxicities, Drug – Drug interactions, Resistance, Medication adherence which might not be able to totally prevent opportunistic infections. So, to prevent these opportunistic infections and progression of disease to AIDS there is a need to identify the factors involved in OI’s occurrence [3]. By this identification of various parameters which are responsible directly or indirectly to opportunistic infections the prediction and prevention action plans can be developed which minimizes the morbidity and mortality due to opportunistic infections in HIV patients.</p>
          <p>
            <bold>Aim</bold>
          </p>
          <p>To study the impact of patient related variables on CD<sub>4</sub> count and opportunistic infections in people living with HIV.</p>
          <p>
            <bold>Objectives</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>To study the correlation between CD<sub>4</sub> count and opportunistic infections.</p>
            </list-item>
            <list-item>
              <p>To assess the impact of socioeconomic status, BMI and medication adherence on prevalence of opportunistic infections in HIV patients with low CD<sub>4</sub> count.</p>
            </list-item>
            <list-item>
              <p>To assess the medication adherence using Morisky et.al Medication Adherence Rating Scale.</p>
            </list-item>
            <list-item>
              <p>To categorize the patient’s anaemic status according to WHO guidelines.</p>
            </list-item>
          </list>
          <p>
            <bold>METHODS AND METHODOLOGY</bold>
          </p>
          <p>
            <bold>Methods</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Study Design: </bold>A Prospective observational study.</p>
            </list-item>
            <list-item>
              <p><bold>Study Site: </bold>Anti Retroviral Therapy (ART) centre in Government General Hospital.</p>
            </list-item>
            <list-item>
              <p><bold>Inclusion Criteria: </bold>All HIV patients who are greater than 13 years and suspected to have opportunistic infections and/or who are diagnosed with any one of the opportunistic infections and consented for study are included<bold>.</bold></p>
            </list-item>
            <list-item>
              <p><bold>Exclusion Criteria: </bold>Terminally ill patients and patients who are unwilling to participate in this study are excluded.</p>
            </list-item>
            <list-item>
              <p><bold>Study Period: </bold>A sample of requisite from 12/2016 (December) to 05/2017 <bold>(</bold>May).</p>
            </list-item>
          </list>
        </sec>
        <sec id="sec-1_1_3">
          <title>Methodology</title>
          <p>This study was conducted from December 2016 to May 2017 in ART Centre at Government General Hospital, Guntur. Patients with HIV are screened for opportunistic infections and patients who are diagnosed with opportunistic infections are included. Inform consent was obtained from each and every patient. History was collected from patients in the data collection form. Patient laboratory details like hemoglobin, CD<sub>4</sub> count and disease specific reports are collected. Patients height, weight are recorded to calculate BMI. Medication adherence was assessed using Morisky et al., Medication Adherence Scale (MMAS) Questionnare. Socioeconomic data was collected by Kuppuswamy’s Socio-Economic Scale. The data was represented in Microsoft excel spreadsheet. Data was analysed and results were drawn.</p>
        </sec>
        <sec id="sec-1_1_4">
          <title>RESULTS</title>
          <p>
            <bold>Figure 1: Pattern of Opportunistic Infections in HIV Patients</bold>
          </p>
          <p>
            <bold>Table 1: Distribution of opportunistic infections in patients with different CD</bold>
            <bold>
              <sub>4</sub>
            </bold>
            <bold> count ranges</bold>
          </p>
          <table-wrap>
            <table>
              <tr>
                <td rowspan="2">
                  <bold>CD</bold>
                  <bold>
                    <sub>4</sub>
                  </bold>
                  <bold> COUNT</bold>
                </td>
                <td rowspan="2">
                  <bold>No. Of patients</bold>
                </td>
                <td colspan="7">
                  <bold>OPPORTUNISTIC INFECTION</bold>
                </td>
              </tr>
              <tr>
                <td/>
                <td/>
                <td>
                  <bold>CNS</bold>
                </td>
                <td>
                  <bold>MSS</bold>
                </td>
                <td>
                  <bold>RESP.</bold>
                </td>
                <td>
                  <bold>GIT</bold>
                </td>
                <td>
                  <bold>HAEM.</bold>
                </td>
                <td>
                  <bold>GUT</bold>
                </td>
                <td>
                  <bold>Commonest</bold>
                </td>
              </tr>
              <tr>
                <td>
                  <bold>&lt;50</bold>
                </td>
                <td>17</td>
                <td>3</td>
                <td>0</td>
                <td>9</td>
                <td>8</td>
                <td>0</td>
                <td>0</td>
                <td>PTB</td>
              </tr>
              <tr>
                <td>
                  <bold>50-100</bold>
                </td>
                <td>22</td>
                <td>4</td>
                <td>0</td>
                <td>6</td>
                <td>11</td>
                <td>1</td>
                <td>1</td>
                <td>Oral candidiasis</td>
              </tr>
              <tr>
                <td>
                  <bold>100-200</bold>
                </td>
                <td>58</td>
                <td>2</td>
                <td>0</td>
                <td>27</td>
                <td>25</td>
                <td>3</td>
                <td>1</td>
                <td>PTB</td>
              </tr>
              <tr>
                <td>
                  <bold>200-300</bold>
                </td>
                <td>58</td>
                <td>3</td>
                <td>0</td>
                <td>21</td>
                <td>31</td>
                <td>5</td>
                <td>2</td>
                <td>Oral candidiasis</td>
              </tr>
              <tr>
                <td>
                  <bold>&gt;350</bold>
                </td>
                <td>59</td>
                <td>1</td>
                <td>1</td>
                <td>14</td>
                <td>39</td>
                <td>1</td>
                <td>4</td>
                <td>Oral candidiasis</td>
              </tr>
            </table>
          </table-wrap>
          <p>
            <bold>Figure 4: Classification of patients having opportunistic infections based on their Body Mass Index</bold>
          </p>
          <p>
            <bold>Table 2: Comparision of BMI and CD</bold>
            <bold>
              <sub>4 </sub>
            </bold>
            <bold>counts</bold>
          </p>
          <table-wrap>
            <table>
              <tr>
                <td rowspan="2">
                  <bold>CD</bold>
                  <bold>
                    <sub>4 </sub>
                  </bold>
                  <bold>COUNT</bold>
                </td>
                <td rowspan="2">
                  <bold>No. of patients with CD</bold>
                  <bold>
                    <sub>4</sub>
                  </bold>
                </td>
                <td colspan="6">
                  <bold>Body Mass Index (in kg/m</bold>
                  <bold>
                    <sup>2</sup>
                  </bold>
                  <bold>)</bold>
                </td>
              </tr>
              <tr>
                <td/>
                <td/>
                <td>
                  <bold>&lt;18.5</bold>
                </td>
                <td>
                  <bold>18.5 to 22</bold>
                </td>
                <td>
                  <bold>22.1 to 24.5</bold>
                </td>
                <td>
                  <bold>24.6 to 29</bold>
                </td>
                <td>
                  <bold>29.1 to 31</bold>
                </td>
                <td>
                  <bold>&gt;31</bold>
                </td>
              </tr>
              <tr>
                <td>&lt;50 cells/µl</td>
                <td>17</td>
                <td>9</td>
                <td>5</td>
                <td>2</td>
                <td>1</td>
                <td>0</td>
                <td>0</td>
              </tr>
              <tr>
                <td>50 to 100 cells/µl</td>
                <td>22</td>
                <td>10</td>
                <td>7</td>
                <td>3</td>
                <td>2</td>
                <td>0</td>
                <td>0</td>
              </tr>
              <tr>
                <td>101 to 200 cells/µl</td>
                <td>58</td>
                <td>21</td>
                <td>24</td>
                <td>8</td>
                <td>4</td>
                <td>1</td>
                <td>0</td>
              </tr>
              <tr>
                <td>201 to 350 cells/µl</td>
                <td>58</td>
                <td>22</td>
                <td>19</td>
                <td>7</td>
                <td>7</td>
                <td>2</td>
                <td>1</td>
              </tr>
              <tr>
                <td>&gt;350 cells/µl</td>
                <td>59</td>
                <td>16</td>
                <td>16</td>
                <td>12</td>
                <td>13</td>
                <td>1</td>
                <td>1</td>
              </tr>
              <tr>
                <td>Total no of patients with BMI</td>
                <td>214</td>
                <td>78</td>
                <td>71</td>
                <td>32</td>
                <td>27</td>
                <td>4</td>
                <td>2</td>
              </tr>
            </table>
          </table-wrap>
          <p>
            <bold>Figure 5:  Number of patients with OI’s at various CD</bold>
            <bold>
              <sub>4 </sub>
            </bold>
            <bold>ranges.</bold>
          </p>
          <p>
            <bold>Figure 6: Duration of diagnosis Vs number of patients</bold>
          </p>
          <p>
            <bold>Figure 7: </bold>
            <bold>Anaemia in patient's having OI's.</bold>
          </p>
          <p>
            <bold>Figure 8:  Socioeconomics status of HIV patients having Opportunistic infections using Kuppuswamy’s  Socioeconomic Scale(KSES)</bold>
          </p>
          <p>
            <bold>Figure 9: </bold>
            <bold>Adherence score Vs Number of patients</bold>
          </p>
          <p>
            <bold>Figure 10: Severity Grading Using JDPV Scale</bold>
          </p>
          <table-wrap>
            <table>
              <tr>
                <td colspan="11">
                  <bold>JOINT DISEASE PREDICTION AND VACTINICATION SCALE</bold>
                </td>
              </tr>
              <tr>
                <td>
                  <bold>PARAMETER</bold>
                </td>
                <td colspan="9">
                  <bold>SCORE</bold>
                </td>
                <td>
                  <bold>PATIENT’S    SCORE</bold>
                </td>
              </tr>
              <tr>
                <td rowspan="2">
                  <bold>AGE</bold>
                </td>
                <td colspan="2">
                  <bold>18-30 yrs</bold>
                </td>
                <td colspan="2">
                  <bold>31-40 yrs</bold>
                </td>
                <td colspan="3">
                  <bold>41-60 yrs</bold>
                </td>
                <td colspan="2">
                  <bold>&gt;60 yrs</bold>
                </td>
                <td/>
              </tr>
              <tr>
                <td/>
                <td colspan="2">3</td>
                <td colspan="2">4</td>
                <td colspan="3">2</td>
                <td colspan="2">1</td>
                <td/>
              </tr>
              <tr>
                <td/>
                <td colspan="2"/>
                <td colspan="2"/>
                <td colspan="3"/>
                <td colspan="2"/>
                <td/>
              </tr>
              <tr>
                <td rowspan="18">
                  <bold>GENDER</bold>
                </td>
                <td colspan="2">
                  <bold>Transgender</bold>
                </td>
                <td colspan="2">
                  <bold>Men</bold>
                </td>
                <td colspan="5">
                  <bold>Women</bold>
                </td>
                <td/>
              </tr>
              <tr>
                <td/>
                <td colspan="2">4</td>
                <td colspan="2">2</td>
                <td colspan="5">3</td>
                <td/>
              </tr>
              <tr>
                <td rowspan="16">
                  <bold>BMI (in kg/ m</bold>
                  <bold>
                    <sup>2</sup>
                  </bold>
                  <bold>)</bold>
                </td>
                <td colspan="2">
                  <bold>≤ 18.5</bold>
                </td>
                <td colspan="2">
                  <bold>18.6 -24.9</bold>
                </td>
                <td colspan="2">
                  <bold>25- 29</bold>
                </td>
                <td colspan="3">
                  <bold>&gt;30</bold>
                </td>
                <td/>
              </tr>
              <tr>
                <td/>
                <td colspan="2">4</td>
                <td colspan="2">2</td>
                <td colspan="2">3</td>
                <td colspan="3">1</td>
                <td/>
              </tr>
              <tr>
                <td rowspan="14">
                  <bold>MONTHLY INCOME(in Rs)</bold>
                </td>
                <td colspan="2">
                  <bold>&lt;6000</bold>
                </td>
                <td colspan="2">
                  <bold>6000-10000</bold>
                </td>
                <td colspan="2">
                  <bold>11000-15000</bold>
                </td>
                <td colspan="3">
                  <bold>&gt;15000</bold>
                </td>
                <td/>
              </tr>
              <tr>
                <td/>
                <td colspan="2">4</td>
                <td colspan="2">3</td>
                <td colspan="2">2</td>
                <td colspan="3">1</td>
                <td/>
              </tr>
              <tr>
                <td rowspan="12">
                  <bold>HIV   DIAGNOSED</bold>
                </td>
                <td colspan="2">
                  <bold>&lt; 1 yr</bold>
                </td>
                <td colspan="2">
                  <bold>1-5 yrs</bold>
                </td>
                <td colspan="2">
                  <bold>6- 10 yrs</bold>
                </td>
                <td colspan="3">
                  <bold>&gt; 10 yrs</bold>
                </td>
                <td/>
              </tr>
              <tr>
                <td/>
                <td colspan="2">3</td>
                <td colspan="2">1</td>
                <td colspan="2">2</td>
                <td colspan="3">4</td>
                <td/>
              </tr>
              <tr>
                <td rowspan="10">
                  <bold>CD </bold>
                  <bold>
                    <sub>4 </sub>
                  </bold>
                  <bold>COUNT</bold>
                  <bold>(cells/mm</bold>
                  <bold>
                    <sup>3</sup>
                  </bold>
                  <bold>)</bold>
                </td>
                <td colspan="2">
                  <bold>≤ 100</bold>
                </td>
                <td colspan="2">
                  <bold>101-350</bold>
                </td>
                <td colspan="2">
                  <bold>350-500</bold>
                </td>
                <td colspan="3">
                  <bold>&gt; 500</bold>
                </td>
                <td/>
              </tr>
              <tr>
                <td/>
                <td colspan="2">4</td>
                <td colspan="2">3</td>
                <td colspan="2">2</td>
                <td colspan="3">1</td>
                <td/>
              </tr>
              <tr>
                <td rowspan="8">
                  <bold>HAEMOGLOBIN</bold>
                  <bold> (in gm/dl)</bold>
                </td>
                <td colspan="2">
                  <bold>≥ 11</bold>
                </td>
                <td colspan="2">
                  <bold>9.5 -10.9</bold>
                </td>
                <td colspan="2">
                  <bold>8-9.4</bold>
                </td>
                <td colspan="2">
                  <bold>6.5- 7.9</bold>
                </td>
                <td>
                  <bold>&lt;6.5</bold>
                </td>
                <td/>
              </tr>
              <tr>
                <td/>
                <td colspan="2">1</td>
                <td colspan="2">1</td>
                <td colspan="2">2</td>
                <td colspan="2">3</td>
                <td>4</td>
                <td/>
              </tr>
              <tr>
                <td rowspan="6">
                  <bold>On ART</bold>
                </td>
                <td>
                  <bold>YES</bold>
                </td>
                <td colspan="8">4</td>
                <td/>
              </tr>
              <tr>
                <td/>
                <td>
                  <bold>NO</bold>
                </td>
                <td colspan="8">1</td>
                <td/>
              </tr>
              <tr>
                <td rowspan="4">
                  <bold>ART  DURATION</bold>
                  <bold>(if applicable)</bold>
                </td>
                <td colspan="2">
                  <bold>&lt; 1yr</bold>
                </td>
                <td>
                  <bold>1- 5 yrs</bold>
                </td>
                <td colspan="2">
                  <bold>6-10 yrs</bold>
                </td>
                <td colspan="4">
                  <bold>&gt; 10 yrs</bold>
                </td>
                <td/>
              </tr>
              <tr>
                <td/>
                <td colspan="2">4</td>
                <td>2</td>
                <td colspan="2">1</td>
                <td colspan="4">3</td>
                <td/>
              </tr>
              <tr>
                <td rowspan="2">
                  <bold>ADHERENCE</bold>
                  <bold>SCORE</bold>
                </td>
                <td colspan="2">
                  <bold>&lt; 6</bold>
                </td>
                <td>
                  <bold>6.1 - 8</bold>
                </td>
                <td colspan="6">
                  <bold>8.1- 9</bold>
                </td>
                <td/>
              </tr>
              <tr>
                <td/>
                <td colspan="2">4</td>
                <td>3</td>
                <td colspan="6">2</td>
                <td/>
              </tr>
              <tr>
                <td colspan="10"><bold>LIFE THREATENING:  </bold>&gt;35<bold>                         HIGH RISK: </bold>26-30<bold>VERY HIGH RISK: </bold>31-35<bold>                         MODERATE RISK: </bold>21-25<bold>LOW RISK: </bold>10-20</td>
                <td>
                  <bold>TOTAL SCORE:</bold>
                </td>
              </tr>
            </table>
          </table-wrap>
        </sec>
        <sec id="sec-1_1_5">
          <title>DISCUSSION</title>
          <p>A total of 214 patients having opportunistic infections were included in the present study. The mean age of patients was found to be 38.28 yrs with a standard deviation of ±9.76. Majority of patients were in the age group between 30 - 40 years. This is similar to the results of study done by Kumar A et al., 55.1% patients were women and 44.1% were men. Gender distribution reveals that women (n=118; 55.1%) are more prone to opportunistic infections when compared to men (n=96; 44.9%). This is comparable to the results of Damtie et al., which might indicate female gender is an independent risk factor for OI’s occurrence [13]. When the upper and lower limits of CD<sub>4</sub> counts at which OIs occur were compared in both of the genders; men were found to have low CD<sub>4</sub> counts when compared to women. This may be due to individual risk factors like anemia, low BMI. This study also reveals that in geriatric HIV seropositives, CD<sub>4</sub> counts are lower. This might be due to other co-morbidities. Though CD<sub>4</sub> counts appears to be above prescribed range in patients who fall in the age group of 41-60 years there is an occasional flair of OIs which may be attributable to advanced clinical stage or disease progression (Fig 5). In our study TB (n=115; 50%) (Fig 1) was the most common OI which is comparable to the study of Ghate et al., (29%) [25]. Other major OI in the current study was candidiasis (47.8%) followed by chronic diarrhoea (1.3%), cryptococcal meningitis (0.43%), PCP (0.43%). 33.4% of OIs are related to respiratory tract leading to mortality in most of the cases. GI related OIs were commonly present at all CD<sub>4</sub> ranges. </p>
          <p>Our study reveals that there is a positive relationship between CD<sub>4</sub> and BMI i.e., as the CD<sub>4</sub> count is decreased gradually there is a steep decline in BMI (Table 2). When the duration ofdiagnosis is between 1-10 years most patients were having normal BMI and CD<sub>4</sub> counts but decreased significantly after this period. This is due to ART which helps to maintain CD<sub>4</sub> count. Progressive decline be attributable to advanced clinical stage, age of the patient, drug resistance and drug toxicities. By observing CD<sub>4</sub> counts at various durations since diagnosis, it was observed CD<sub>4</sub> count was well maintained up to 13 years which shows ART was effective to prolong the lifespan of PLHIV (People Living with HIV). Grade II anaemia was predominantly seen in patients and it also depicts that every individual with OI have some degree of anemia (Fig 7). This, if unmanaged at appropriate time, may lead to rapid advancement in clinical stage which may lead to ART failure requiring therapy switch or substitution. There is an acceptable relationship between adherence and BMI. When mean BMI values and adherence score were compared, mean BMI value increased gradually from poor adherent to highly adherent patients. Incidence of OI’s was high in poorly and moderately adherent patients when compared to highly adherent patients [27-33]. All these parameters are brought together to assess HIV patients individual risk for developing opportunistic infections using a suitable scale. Joint Disease Prediction and Vaticination Scale (JDPV) was developed and validated by implementing in opportunistic infections having patients (Annexure I). All the patients fall above or with in moderate risk categories and this reveals that JDPV Scale (Fig. 10) is strong enough to identify the individual patient risk.</p>
        </sec>
        <sec id="sec-1_1_6">
          <title>CONCLUSION</title>
          <p>In conclusion our study demonstrates that though CD<sub>4</sub> count appears to be above the prescribed range, presence of opportunistic infections indicate that once HIV infection happens immunosuppression is a must, the scales tip towards predisposition to infection. GI related opportunistic infections are commonly seen in majority of patients irrespective of CD<sub>4</sub> count. Anaemia is the major concern to be addressed in order to maintain and improve overall health. Usually CD<sub>4</sub> count is the only predictor used for assessing patient’s risk for developing opportunistic infections. But there are certain other factors which influence incidence of opportunistic infections. Thus, there is a necessity for development of a predictive scale which is easily reproducible, commonly applicable and user friendly. Joint Disease Prediction and Vactinication Scale (JDPV) is an outcome to fulfill this requirement and enhance quality of care provided to HIV patients. By applying JDPV scale, risk for developing opportunistic infections can be duly assessed and appropriate risk minimization plan can be implemented to prevent the morbidity and mortality due to opportunistic infections.</p>
        </sec>
        <sec id="sec-1_1_7">
          <title>FUTURE PROSPECTUS</title>
          <list list-type="order">
            <list-item>
              <p>Our study reveals there was a positive relationship between CD<sub>4</sub> count and Body Mass Index of patient, but the reason for association can’t be clearly established due to inadequate sample size. Thus, there is a need for further studies to explain this association in detail.</p>
            </list-item>
            <list-item>
              <p>JDPV scale was analyzed for its efficacy in limited sample, for its further improvement need to be studied in a large sample size.</p>
            </list-item>
            <list-item>
              <p>Scale is confined to adult and elderly population. So, future studies concentrating on pediatric population should be encouraged.</p>
            </list-item>
            <list-item>
              <p>Opportunistic infections are mostly seen in women compared to men and reasons need to be investigated in future studies.</p>
            </list-item>
          </list>
        </sec>
        <sec id="sec-1_1_8">
          <title>REFERENCES</title>
          <list list-type="bullet">
            <list-item>
              <p>Longo, Kasper, Fauci, Hauser, Jameson, Loascalzo. Infections due to Human Immunodeficency Virus. Harrison’s Principles of Internal Medicine 2(2), 2012, 2138-2159.</p>
            </list-item>
            <list-item>
              <p>National AIDS Control Organisation. Annual report 2015-16.NACO 24, 2016, 335-395. </p>
            </list-item>
            <list-item>
              <p>Maria Cheng. AIDS to be third leading cause of death. Associated Press/USA Today.  28, 2006, 2-4.</p>
            </list-item>
            <list-item>
              <p>Lindsay C. Bacik, B.S, Dr. Futou Seck, Dr. Rhonda BeLue1.Spectrum of Comorbid Conditions and Their Relationship to CD<sub>4</sub> T-lymphocyte Counts in HIV-Infected Patients in Mbour, Senegal<bold>.</bold><bold>J Glob Health</bold> 2017.</p>
            </list-item>
            <list-item>
              <p>Kumar A, Singh S, Sahu NP. Evaluation of CD<sub>4</sub> count and correlation with development of opportunistic infection among HIV seropositives. Eastern J Med Sci 1(1), 2016, 12-16. </p>
            </list-item>
            <list-item>
              <p>Bhusal KR, Devkota S, Shrestha M, Khadga P. Profile of Anaemia in HIV Positive Patients. JCMS Nepal; 12(2), 2016, 70-3.</p>
            </list-item>
            <list-item>
              <p>John Rubaihayo, Nazarius M Tumwesigye1 and Joseph Konde-Lule1. Trends in prevalence of selected opportunistic infections associated with HIV/AIDS in Uganda. BMC Infectious Diseases  2015, 15:187.</p>
            </list-item>
            <list-item>
              <p>Aishwarya. R. Assessment of Nutritional Status of people living with HIV/AIDS (PLWHA) in the age group of 18-55 years. IOSR-JNHS 4(2), 2015, 17-28.</p>
            </list-item>
            <list-item>
              <p>Muluken Assefa M, Abegaz W, Shewamare A, Medhin M, Belay M. Prevalence and correlates of Anaemia among HIV infected patients on highly active retroviral therapy. BMC Hematology, Ethiopia, 2015, 15: 6.</p>
            </list-item>
            <list-item>
              <p>Moges NA, Kassa GM. Prevalence of Opportunistic Infections and Associated Factors among HIV Positive Patients taking Anti-Retroviral Therapy in DebreMarkos Referral Hospital, Northwest Ethiopia. J AIDS Clin Res 2014, 5: 301.</p>
            </list-item>
            <list-item>
              <p>Catherine Martin, Poudel-Tandukar K, Poudel KC. HIV Symptom Burden and Anemia among HIV-Positive Individuals: Cross-Sectional Results of a Community-Based Positive Living with HIV (POLH) Study in Nepal. PLoS ONE 9(12), 2014, e116263. </p>
            </list-item>
            <list-item>
              <p>Woldesellassie M. Bezabhe, Leanne Chalmers, Luke R. Bereznicki, Gregory M. Peterson, Mekides A. Bimirew, Desalew M. Kassie. Barriers and Facilitators of Adherence to Antiretroviral Drug Therapy and Retention in Care among Adult HIV-Positive Patients: A Qualitative Study from Ethiopia. PLoS ONE 9(5), 2014,  e97353. </p>
            </list-item>
            <list-item>
              <p>Debasu Damtie, Gizachew Yismaw, Desalegn Woldeyohannes and Belay Anagaw. Common opportunistic infections and their CD<sub>4</sub> cell correlates among HIV-infected patients attending at antiretroviral therapy clinic of Gondar University Hospital, Northwest Ethiopia. BMC Research Notes 2013, 6:534.</p>
            </list-item>
            <list-item>
              <p>Bach Xuan Tran, Long Thanh Nguyen, Nga Hoang Nguyen, Quynh Van Hoang and Jongnam Hwang. Determinants of antiretroviral treatment adherence among HIV/AIDS patients: a multisite study. Glob Health Action 2013, 6: 19570.</p>
            </list-item>
            <list-item>
              <p>Sandeep Rai, Bidhubhusan Mahapatra, Subhashish Sircar, Pinnamaneni Yujwal Raj, Srinivasan Venkatesh, Mohammed Shaukat, Bharat Bhusan Rewari. Adherence to Antiretroviral Therapy and Its Effect on Survival of HIV-Infected Individuals in Jharkhand, India. PLoS ONE 8(6), 2013, e66860.  </p>
            </list-item>
            <list-item>
              <p>Banwat ME, Yakubu NW, Olalude EO, Ogunsakin JA. An Assessment of the Nutritional Knowledge, Practice and Status of Adult HIV/Aids Patients Attending an Art Centre in Jos, North Central Nigeria. Health Care Current Reviews (1), 2013, 101.  </p>
            </list-item>
            <list-item>
              <p>Ana Célia Oliveira dos Santos and Ana Maria Rampeloti Almeida. Nutritional status and CD<sub>4</sub> cell counts in patients with HIV/AIDS receiving antiretroviral therapy. Revista da Sociedade Brasileira de Medicina Tropical, 46(6), 2013, 698-703.</p>
            </list-item>
            <list-item>
              <p>Iroezindu MO, Ofondu EO, Hausler H, Wyk BV. Prevalence and Risk Factors for Opportunistic Infections in HIV Patients Receiving Antiretroviral Therapy in a Resource-Limited Setting in Nigeria. J AIDS Clinic Res 2013, S3:002.  </p>
            </list-item>
            <list-item>
              <p>Shen Y, Wang Z, Lu H, Wang J, Chen J. Prevalence of Anemia among Adults with Newly Diagnosed HIV/AIDS in China. PLoS ONE 8(9), 2013, e73807.  </p>
            </list-item>
            <list-item>
              <p>Anant A. Takalkar, G.S. Saiprasad, V .G. Prasad, Narendra S. Madhekar. Study of Opportunistic Infections in HIV Seropositive Patients Admitted to Community Care centre (CCC), KIMS Narketpally.Biomedical Research 23(1), 2012, 139-142</p>
            </list-item>
            <list-item>
              <p>Carolline de Araújo Mariz, Maria de Fátima P. Militão de Albuquerque, Ricardo Arraes de Alencar Ximenes, Heloísa Ramos Lacerda de Melo, Francisco Bandeira, Thaís Gelenske Braga e Oliveira, Érico Higino de Carvalho, Adriana Paula da Silva, Demócrito de Barros Miranda Filho. Body mass index in individuals with HIV infection and factors associated with thinness and overweight/obesity. Cad. Saúde Pública, Rio de Janeiro; 27(10), 2011, 1997-2008.</p>
            </list-item>
            <list-item>
              <p>N. Joglekar, R. Paranjape, R. Jain, G. Rahane, R. Potdar, K.S. Reddy &amp; S. Sahay. Barriers to ART adherence &amp; follow ups among patients attending ART centres in Maharashtra, India. Indian J Med Res 134, 2011, 954-959.</p>
            </list-item>
            <list-item>
              <p>Samuel N. Obi, Ngozi A. Ifebunandu, Azubuike K. Onyebuchi. Nutritional status of HIV-positive individuals on free HAART treatment in a developing nation. J Infect Dev Ctries 4(11), 2010, 745-749.</p>
            </list-item>
            <list-item>
              <p>Crum-Cianflone N, Roediger MP, Eberly L, Headd M, Marconi V, et al. Increasing Rates of Obesity among HIV-Infected Persons during the HIV Epidemic. PLoS ONE; 5(4), 2010, e10106.  </p>
            </list-item>
            <list-item>
              <p>Manisha Ghate , Swapna Deshpande , Srikanth Tripathy , Madhura Nene ,Preeti Gedam , Sheela Godbole , Madhuri Thakar , Arun Risbud ,Robert Bollinger , Sanjay Mehendale. Incidence of common opportunistic infections in HIV-infected individuals in Pune, India: analysis by stages of immunosuppression represented by CD<sub>4</sub> counts. International Journal of Infectious Diseases 13, 2009, e1—e8.</p>
            </list-item>
            <list-item>
              <p>Mary B Cauldbeck, Catherine O'Connor et al. Adherence to anti-retroviral therapy among HIV patients in Bangalore, India<bold>. </bold>AIDS Res Ther. 2009, 6: 7.  </p>
            </list-item>
            <list-item>
              <p>Sheri D. Weiser, MD, MPH, Kimberly A. Fernandes, MSC, Eirikka K. Brandson, MPH,Viviane D. Lima, PhD, Aranka Anema, MSc, David R. Bangsberg, MD, MPH, Julio S.Montaner, MD, FRCPC, and Robert S. Hogg, PhD. The association between food insecurity and mortality among HIV-infected individuals on HAART, J Acquir Immune Defic Syndr.  52(3), 2009, 342–349.</p>
            </list-item>
            <list-item>
              <p>Ruth Joy, MSc, Eric F. Druyts, MSc, Eirikka K. Brandson, MSc, Viviane D. Lima, PhD,Clare A. Rustad, MPhil, Wendy Zhang, MSc, Evan Wood, MD, PhD, Julio S. G. Montaner, MD, FRCPC, FCCP, and Robert S. Hogg, PhD.Impact of Neighborhood-Level Socioeconomic Status on HIV Disease Progression in a Universal Health Care Setting, J Acquir Immune Defic Syndr 47, 2008, 500–505.</p>
            </list-item>
            <list-item>
              <p>Ledergerber B, Egger M, Erard V, Weber R, Hirschel B, et al. AIDS related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA. 282, 1999, 2220-2226.</p>
            </list-item>
            <list-item>
              <p>Srirangaraj S, Venkatesha D Opportunistic infections in relation to antiretroviral status among AIDS patients from south India. Indian J Med Microbiol 29, 2011, 395-400.</p>
            </list-item>
            <list-item>
              <p>Kaplan JE, Hanson D, Dworkin MS, Frederick T, Bertolli J, et al. Epidemiology of human immunodeficiency virus–associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 30, 2000, 5-14.</p>
            </list-item>
            <list-item>
              <p>Lawn SD, Badri M, Wood R Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. AIDS. 19, 2005, 2109-2116.</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </sec>
  </body>
  <back/>
</article>
